The Mental Health Watchdog calls for reforms to protect public safety, citing decades of antidepressant, electroshock, and psychedelic drug risks.

OBODENCE™ and XBRYK™ recommended for approval by the European Medicines Agency for all indications referencing Prolia and Xgeva, respectively INCHEON, South Korea, Nov. 15, 2024 (GLOBE NEWSWIRE) -- ...

The teenager used to think his diagnosis was a burden. Now the budding young musician realises it is helping him play to his ...

A new state report shows most local governments in Indiana have not started spending their portion of opioid settlement ...

Family stories — including stories about illness — are important in articulating family values and increasing family ...

The prescribing of antiviral drugs for US children and adolescents receiving treatment for influenza was less than 60% in the ...

Treatments for hair regrowth include medicated formulas, supplements, lasers, and complementary remedies, such as massage and ...

The first depression health economic modeling study, led by Professor Shirley Li Xue, from the LKS Faculty of Medicine, the ...

As optimism for GLP-1 receptor agonists for weight loss has grown, so too has their use in children. Currently, liraglutide ...

The FDA has approved Nerivio REN to include the acute and/or preventive treatment of migraine in patients 8 years of age and older.

In alignment with Egypt's Vision 2030 for healthcare and based on the directives of President Abdel-Fattah El-Sisi and as ...

The FDA has accepted Sanofi and Regeneron’s application to expand Dupixent’s use, with a decision expected by April 2025.